CN Stock MarketDetailed Quotes

300759 Pharmaron Beijing

Watchlist

23.61
+0.21+0.90%

Market Closed May 14 15:00 CST

41.98BMarket Cap22.46P/E (TTM)

Pharmaron Beijing Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

Total operating revenue

16.03%3.1B

6.39%12.28B

3.00%8.82B

-0.63%5.6B

-1.95%2.67B

12.39%11.54B

15.64%8.56B

21.70%5.64B

29.53%2.72B

37.92%10.27B

Operating revenue

16.03%3.1B

6.39%12.28B

3.00%8.82B

-0.63%5.6B

-1.95%2.67B

12.39%11.54B

15.64%8.56B

21.70%5.64B

29.53%2.72B

37.92%10.27B

Other operating revenue

----

38.79%6.4M

----

1.33%3.06M

----

-82.39%4.61M

----

-69.21%3.02M

----

6.99%26.19M

Total operating cost

11.25%2.71B

8.45%10.64B

5.70%7.77B

3.59%4.99B

3.70%2.44B

12.08%9.81B

16.94%7.35B

21.53%4.82B

27.96%2.35B

45.71%8.75B

Operating cost

14.31%2.06B

8.89%8.07B

6.36%5.83B

3.96%3.73B

2.84%1.8B

14.09%7.41B

16.60%5.48B

19.23%3.59B

24.28%1.75B

36.37%6.5B

Operating tax surcharges

-21.64%23.24M

32.56%109.7M

44.28%85M

49.43%59.15M

74.27%29.65M

24.40%82.75M

19.99%58.91M

27.12%39.58M

22.74%17.01M

51.05%66.52M

Operating expense

24.12%68.85M

2.24%258.43M

-3.80%186.56M

-3.02%122.95M

-0.41%55.47M

9.87%252.78M

18.94%193.92M

17.27%126.78M

18.95%55.7M

47.84%230.07M

Administration expense

-0.42%396.94M

-1.36%1.58B

-0.62%1.21B

-1.10%804.05M

-3.81%398.61M

7.26%1.61B

17.15%1.21B

27.92%812.97M

42.63%414.38M

72.79%1.5B

Financial expense

-26.58%46.58M

2,615.63%142.87M

21.96%132.74M

-2.63%66.34M

61.25%63.44M

-97.03%5.26M

-32.76%108.84M

-29.14%68.14M

-2.22%39.34M

662.75%177.03M

-Interest expense (Financial expense)

-37.82%43.88M

33.77%243.72M

44.25%193.42M

55.29%138.25M

50.77%70.57M

8.89%182.19M

7.64%134.09M

9.60%89.03M

18.33%46.81M

101.40%167.31M

-Interest Income (Financial expense)

72.35%-6.73M

-119.51%-73.63M

-204.81%-65.38M

-257.36%-50.88M

-272.73%-24.33M

4.74%-33.54M

28.17%-21.45M

38.90%-14.24M

47.91%-6.53M

45.33%-35.21M

Research and development

30.56%122.21M

4.68%469.26M

11.96%332.25M

14.06%207.8M

21.82%93.61M

58.78%448.28M

67.22%296.76M

117.74%182.18M

93.81%76.84M

86.02%282.32M

Credit Impairment Loss

-83.27%-11.39M

-28.10%-40.78M

-41.74%-24.85M

-108.24%-22.19M

-120.96%-6.22M

-56.86%-31.84M

-99.30%-17.53M

-90.39%-10.66M

-222.62%-2.81M

-114.13%-20.3M

Asset Impairment Loss

1,697.38%4.06M

-652.64%-94.49M

20.53%-4.83M

99.93%-1.85K

83.58%-254.36K

-162.76%-12.55M

-84.18%-6.08M

13.76%-2.83M

42.24%-1.55M

-31.52%-4.78M

Other net revenue

-157.30%-21.22M

291.59%466.37M

374.69%583.84M

554.89%618.36M

-38.14%37.04M

-32.04%119.1M

12.16%122.99M

16.69%94.42M

7.83%59.87M

-63.25%175.24M

Fair value change income

-1,035.82%-12.8M

-91.77%1.54M

-155.03%-22.12M

-106.66%-2.55M

-103.94%-1.13M

-72.47%18.75M

-48.12%40.2M

-33.55%38.32M

-36.42%28.58M

-43.06%68.09M

Invest income

-131.42%-14.63M

1,093.81%542.07M

1,158.41%616.4M

1,389.79%634.1M

177.35%46.57M

-39.07%45.41M

154.11%48.98M

147.86%42.56M

588.88%16.79M

-75.77%74.53M

-Including: Investment income associates

-82.62%-22.8M

-5,814.47%-123.26M

-577.20%-53.82M

-375.97%-30.31M

-204.77%-12.48M

93.84%-2.08M

222.47%11.28M

347.40%10.98M

260.95%11.92M

-147.12%-33.85M

Asset deal income

98.45%-310.59K

-42,680.44%-25.38M

-9,732.09%-23.92M

-61,540.72%-20.78M

-17,640.70%-20M

104.91%59.6K

118.51%248.31K

120.30%33.82K

124.01%114K

11.49%-1.21M

Other revenue

-23.33%13.85M

-15.98%83.41M

-24.52%43.16M

10.33%29.79M

-3.66%18.06M

68.51%99.27M

117.11%57.18M

78.45%27M

108.49%18.75M

-8.22%58.91M

Operating profit

35.56%363.87M

13.88%2.1B

22.49%1.63B

34.51%1.23B

-37.81%268.41M

9.35%1.85B

8.62%1.33B

22.02%913.88M

34.84%431.57M

-11.72%1.69B

Add:Non operating Income

-69.23%151.21K

-65.85%1.66M

-64.56%1.2M

-69.61%802.98K

35.92%491.49K

51.71%4.85M

57.35%3.39M

70.81%2.64M

-52.62%361.61K

-43.96%3.2M

Less:Non operating expense

52.26%437.24K

0.01%14.86M

-39.96%6.56M

-60.02%3.2M

-94.61%287.17K

-44.36%14.85M

-38.21%10.93M

2.62%8M

14.68%5.33M

195.12%26.7M

Total profit

35.35%363.59M

13.79%2.09B

22.78%1.62B

35.04%1.23B

-37.03%268.62M

10.29%1.84B

9.40%1.32B

22.33%908.52M

34.92%426.6M

-12.80%1.67B

Less:Income tax cost

59.27%83.93M

47.25%377.1M

35.54%252.67M

15.63%143.9M

-31.07%52.7M

-18.50%256.11M

-29.20%186.42M

-29.84%124.46M

-3.50%76.45M

8.02%314.25M

Net profit

29.52%279.65M

8.37%1.71B

20.69%1.37B

38.12%1.08B

-38.33%215.92M

16.98%1.58B

20.16%1.13B

38.70%784.07M

47.77%350.15M

-16.54%1.35B

Net profit from continuing operation

29.52%279.65M

8.37%1.71B

20.69%1.37B

38.12%1.08B

-38.33%215.92M

16.98%1.58B

20.16%1.13B

38.70%784.07M

47.77%350.15M

-16.54%1.35B

Less:Minority Profit

-77.08%-25.92M

-309.99%-79.19M

-1,064.87%-52.59M

-1,403.81%-30.46M

-873.86%-14.64M

14.03%-19.32M

73.33%-4.51M

89.94%-2.03M

115.59%1.89M

45.14%-22.47M

Net profit of parent company owners

32.54%305.58M

12.01%1.79B

24.82%1.42B

41.64%1.11B

-33.80%230.56M

16.48%1.6B

18.51%1.14B

34.28%786.09M

39.81%348.26M

-17.24%1.37B

Earning per share

Basic earning per share

33.54%0.1736

12.18%1.0133

24.85%0.8028

41.42%0.6282

-33.94%0.13

16.55%0.9033

18.81%0.643

34.85%0.4442

-6.42%0.1968

-44.60%0.775

Diluted earning per share

33.51%0.1733

12.13%1.0113

24.89%0.8019

41.37%0.6271

-34.01%0.1298

16.54%0.9019

18.75%0.6421

34.71%0.4436

-6.29%0.1967

-43.47%0.7739

Other composite income

306.50%110.02M

19.61%-903.8K

324.93%60.88M

-187.58%-32.53M

-6,022.01%-53.28M

-100.91%-1.12M

40.05%-27.07M

197.35%37.14M

98.42%-870.26K

242.74%123.2M

Other composite income of parent company owners

293.73%106.3M

17.23%-2.93M

313.06%56.54M

-198.67%-37.51M

-4,708.56%-54.87M

-102.87%-3.54M

38.56%-26.54M

202.71%38.02M

97.92%-1.14M

242.86%123.11M

Other composite income of minority owners

132.86%3.71M

-16.12%2.02M

922.59%4.34M

670.42%4.98M

488.61%1.59M

2,406.21%2.41M

73.04%-527.27K

23.44%-873.03K

549.75%270.87K

170.97%96.27K

Total composite income

139.59%389.67M

8.39%1.71B

29.13%1.43B

27.91%1.05B

-53.43%162.64M

7.14%1.58B

23.18%1.11B

55.78%821.21M

91.99%349.28M

-3.81%1.48B

Total composite income of parent company owners

134.44%411.88M

12.07%1.79B

32.88%1.48B

30.55%1.08B

-49.39%175.69M

6.67%1.6B

21.20%1.11B

50.27%824.11M

78.81%347.11M

-4.90%1.5B

Total composite income of minority owners

-70.26%-22.21M

-356.55%-77.17M

-857.04%-48.26M

-779.01%-25.48M

-703.20%-13.04M

24.44%-16.9M

73.30%-5.04M

86.38%-2.9M

117.73%2.16M

45.55%-22.37M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Ernst & Young Huaming Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022
Total operating revenue	16.03%3.1B	6.39%12.28B	3.00%8.82B	-0.63%5.6B	-1.95%2.67B	12.39%11.54B	15.64%8.56B	21.70%5.64B	29.53%2.72B	37.92%10.27B
Operating revenue	16.03%3.1B	6.39%12.28B	3.00%8.82B	-0.63%5.6B	-1.95%2.67B	12.39%11.54B	15.64%8.56B	21.70%5.64B	29.53%2.72B	37.92%10.27B
Other operating revenue	----	38.79%6.4M	----	1.33%3.06M	----	-82.39%4.61M	----	-69.21%3.02M	----	6.99%26.19M
Total operating cost	11.25%2.71B	8.45%10.64B	5.70%7.77B	3.59%4.99B	3.70%2.44B	12.08%9.81B	16.94%7.35B	21.53%4.82B	27.96%2.35B	45.71%8.75B
Operating cost	14.31%2.06B	8.89%8.07B	6.36%5.83B	3.96%3.73B	2.84%1.8B	14.09%7.41B	16.60%5.48B	19.23%3.59B	24.28%1.75B	36.37%6.5B
Operating tax surcharges	-21.64%23.24M	32.56%109.7M	44.28%85M	49.43%59.15M	74.27%29.65M	24.40%82.75M	19.99%58.91M	27.12%39.58M	22.74%17.01M	51.05%66.52M
Operating expense	24.12%68.85M	2.24%258.43M	-3.80%186.56M	-3.02%122.95M	-0.41%55.47M	9.87%252.78M	18.94%193.92M	17.27%126.78M	18.95%55.7M	47.84%230.07M
Administration expense	-0.42%396.94M	-1.36%1.58B	-0.62%1.21B	-1.10%804.05M	-3.81%398.61M	7.26%1.61B	17.15%1.21B	27.92%812.97M	42.63%414.38M	72.79%1.5B
Financial expense	-26.58%46.58M	2,615.63%142.87M	21.96%132.74M	-2.63%66.34M	61.25%63.44M	-97.03%5.26M	-32.76%108.84M	-29.14%68.14M	-2.22%39.34M	662.75%177.03M
-Interest expense (Financial expense)	-37.82%43.88M	33.77%243.72M	44.25%193.42M	55.29%138.25M	50.77%70.57M	8.89%182.19M	7.64%134.09M	9.60%89.03M	18.33%46.81M	101.40%167.31M
-Interest Income (Financial expense)	72.35%-6.73M	-119.51%-73.63M	-204.81%-65.38M	-257.36%-50.88M	-272.73%-24.33M	4.74%-33.54M	28.17%-21.45M	38.90%-14.24M	47.91%-6.53M	45.33%-35.21M
Research and development	30.56%122.21M	4.68%469.26M	11.96%332.25M	14.06%207.8M	21.82%93.61M	58.78%448.28M	67.22%296.76M	117.74%182.18M	93.81%76.84M	86.02%282.32M
Credit Impairment Loss	-83.27%-11.39M	-28.10%-40.78M	-41.74%-24.85M	-108.24%-22.19M	-120.96%-6.22M	-56.86%-31.84M	-99.30%-17.53M	-90.39%-10.66M	-222.62%-2.81M	-114.13%-20.3M
Asset Impairment Loss	1,697.38%4.06M	-652.64%-94.49M	20.53%-4.83M	99.93%-1.85K	83.58%-254.36K	-162.76%-12.55M	-84.18%-6.08M	13.76%-2.83M	42.24%-1.55M	-31.52%-4.78M
Other net revenue	-157.30%-21.22M	291.59%466.37M	374.69%583.84M	554.89%618.36M	-38.14%37.04M	-32.04%119.1M	12.16%122.99M	16.69%94.42M	7.83%59.87M	-63.25%175.24M
Fair value change income	-1,035.82%-12.8M	-91.77%1.54M	-155.03%-22.12M	-106.66%-2.55M	-103.94%-1.13M	-72.47%18.75M	-48.12%40.2M	-33.55%38.32M	-36.42%28.58M	-43.06%68.09M
Invest income	-131.42%-14.63M	1,093.81%542.07M	1,158.41%616.4M	1,389.79%634.1M	177.35%46.57M	-39.07%45.41M	154.11%48.98M	147.86%42.56M	588.88%16.79M	-75.77%74.53M
-Including: Investment income associates	-82.62%-22.8M	-5,814.47%-123.26M	-577.20%-53.82M	-375.97%-30.31M	-204.77%-12.48M	93.84%-2.08M	222.47%11.28M	347.40%10.98M	260.95%11.92M	-147.12%-33.85M
Asset deal income	98.45%-310.59K	-42,680.44%-25.38M	-9,732.09%-23.92M	-61,540.72%-20.78M	-17,640.70%-20M	104.91%59.6K	118.51%248.31K	120.30%33.82K	124.01%114K	11.49%-1.21M
Other revenue	-23.33%13.85M	-15.98%83.41M	-24.52%43.16M	10.33%29.79M	-3.66%18.06M	68.51%99.27M	117.11%57.18M	78.45%27M	108.49%18.75M	-8.22%58.91M
Operating profit	35.56%363.87M	13.88%2.1B	22.49%1.63B	34.51%1.23B	-37.81%268.41M	9.35%1.85B	8.62%1.33B	22.02%913.88M	34.84%431.57M	-11.72%1.69B
Add:Non operating Income	-69.23%151.21K	-65.85%1.66M	-64.56%1.2M	-69.61%802.98K	35.92%491.49K	51.71%4.85M	57.35%3.39M	70.81%2.64M	-52.62%361.61K	-43.96%3.2M
Less:Non operating expense	52.26%437.24K	0.01%14.86M	-39.96%6.56M	-60.02%3.2M	-94.61%287.17K	-44.36%14.85M	-38.21%10.93M	2.62%8M	14.68%5.33M	195.12%26.7M
Total profit	35.35%363.59M	13.79%2.09B	22.78%1.62B	35.04%1.23B	-37.03%268.62M	10.29%1.84B	9.40%1.32B	22.33%908.52M	34.92%426.6M	-12.80%1.67B
Less:Income tax cost	59.27%83.93M	47.25%377.1M	35.54%252.67M	15.63%143.9M	-31.07%52.7M	-18.50%256.11M	-29.20%186.42M	-29.84%124.46M	-3.50%76.45M	8.02%314.25M
Net profit	29.52%279.65M	8.37%1.71B	20.69%1.37B	38.12%1.08B	-38.33%215.92M	16.98%1.58B	20.16%1.13B	38.70%784.07M	47.77%350.15M	-16.54%1.35B
Net profit from continuing operation	29.52%279.65M	8.37%1.71B	20.69%1.37B	38.12%1.08B	-38.33%215.92M	16.98%1.58B	20.16%1.13B	38.70%784.07M	47.77%350.15M	-16.54%1.35B
Less:Minority Profit	-77.08%-25.92M	-309.99%-79.19M	-1,064.87%-52.59M	-1,403.81%-30.46M	-873.86%-14.64M	14.03%-19.32M	73.33%-4.51M	89.94%-2.03M	115.59%1.89M	45.14%-22.47M
Net profit of parent company owners	32.54%305.58M	12.01%1.79B	24.82%1.42B	41.64%1.11B	-33.80%230.56M	16.48%1.6B	18.51%1.14B	34.28%786.09M	39.81%348.26M	-17.24%1.37B
Earning per share
Basic earning per share	33.54%0.1736	12.18%1.0133	24.85%0.8028	41.42%0.6282	-33.94%0.13	16.55%0.9033	18.81%0.643	34.85%0.4442	-6.42%0.1968	-44.60%0.775
Diluted earning per share	33.51%0.1733	12.13%1.0113	24.89%0.8019	41.37%0.6271	-34.01%0.1298	16.54%0.9019	18.75%0.6421	34.71%0.4436	-6.29%0.1967	-43.47%0.7739
Other composite income	306.50%110.02M	19.61%-903.8K	324.93%60.88M	-187.58%-32.53M	-6,022.01%-53.28M	-100.91%-1.12M	40.05%-27.07M	197.35%37.14M	98.42%-870.26K	242.74%123.2M
Other composite income of parent company owners	293.73%106.3M	17.23%-2.93M	313.06%56.54M	-198.67%-37.51M	-4,708.56%-54.87M	-102.87%-3.54M	38.56%-26.54M	202.71%38.02M	97.92%-1.14M	242.86%123.11M
Other composite income of minority owners	132.86%3.71M	-16.12%2.02M	922.59%4.34M	670.42%4.98M	488.61%1.59M	2,406.21%2.41M	73.04%-527.27K	23.44%-873.03K	549.75%270.87K	170.97%96.27K
Total composite income	139.59%389.67M	8.39%1.71B	29.13%1.43B	27.91%1.05B	-53.43%162.64M	7.14%1.58B	23.18%1.11B	55.78%821.21M	91.99%349.28M	-3.81%1.48B
Total composite income of parent company owners	134.44%411.88M	12.07%1.79B	32.88%1.48B	30.55%1.08B	-49.39%175.69M	6.67%1.6B	21.20%1.11B	50.27%824.11M	78.81%347.11M	-4.90%1.5B
Total composite income of minority owners	-70.26%-22.21M	-356.55%-77.17M	-857.04%-48.26M	-779.01%-25.48M	-703.20%-13.04M	24.44%-16.9M	73.30%-5.04M	86.38%-2.9M	117.73%2.16M	45.55%-22.37M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	Ernst & Young Huaming Certified Public Accountants (Special General Partnership)	--	--	--	Ernst & Young Huaming Certified Public Accountants (Special General Partnership)	--	--	--	Ernst & Young Huaming Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

300759 Pharmaron Beijing

Pharmaron Beijing Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Market Insights

Discussing

Latest News

Investment Course